English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 22, 2025

Patient regains clear vision with UTHealth Houston's advanced eye care
+ Pharmaceuticals
Patient Daily | Apr 22, 2025

Strategies for maintaining weight after weight loss medications
+ Pharmaceuticals
Patient Daily | Apr 21, 2025

Maternal COVID-19 prompts stress responses in placenta, study reveals
+ Regulatory
C.D. Marsden | Apr 18, 2025

FDA Commissioner Makary: 'We are removing industry members—Pharma members—from FDA advisory committees'
+ Pharmaceuticals
Patient Daily | Apr 18, 2025

Research identifies GPKOW gene variants linked to developmental disorder
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

AI tool decodes cerebellar signals to improve understanding of brain disorders

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones